TomBrooksVaughanIIIMD(Brooks)
Endocrinology • Birmingham, ALDiabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology, Thyroid
Professor, Medicine, University of Alabama School of Medicine
Dr. Vaughan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1717 6th Ave S
Birmingham, AL 35233Phone+1 800-822-8816Fax+1 205-801-8798
Summary
- Dr. Tom Vaughan is an endocrinologist in Birmingham, AL and is affiliated with multiple hospitals in the area, including Birmingham Veterans Affairs Medical Center and University of Alabama Hospital. He received his medical degree from University of Alabama School of Medicine and has been in practice 21 years. He specializes in diabetes, lipid metabolism, pituitary disorders & neuroendocrinology, and thyroid and is experienced in diabetes mellitus, obesity and obesity-related disorders, lipid metabolism disorders, acromegaly, and pituitary gigantism.
Education & Training
University of Alabama Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2006
University of MinnesotaResidency, Internal Medicine/Pediatrics, 2000 - 2004
University of Alabama School of MedicineClass of 2000
Certifications & Licensure
AL State Medical License 2004 - 2024
MN State Medical License 2003 - 2004- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD) Start of enrollment: 2024 Jul 15
- A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency Start of enrollment: 2021 Dec 16
- A Study to Assess the Safety, Tolerability, and Efficacy of IONIS-GHR-LRx Administered in Patients With Acromegaly Start of enrollment: 2021 Jan 04
- Join now to see all
Publications & Presentations
PubMed
- 48 citationsPsychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas.Adriana G. Ioachimescu, Maria Fleseriu, Andrew R. Hoffman, T. Brooks Vaughan, Laurence Katznelson
European Journal of Endocrinology. 2019-01-01 - 25 citationsLong-Term Survival After Transformation of an Adrenocorticotropic Hormone-Secreting Pituitary Macroadenoma to a Silent Corticotroph Pituitary Carcinoma.Lauren E. Rotman, T. Brooks Vaughan, James R. Hackney, Kristen O. Riley
World Neurosurgery. 2019-02-01 - 24 citationsSustained weight loss in patients treated with mifepristone for Cushing's syndrome: a follow-up analysis of the SEISMIC study and long-term extension.Henry G. Fein, T. Brooks Vaughan, Harvey Kushner, David Cram, Dat Nguyen
BMC Endocrine Disorders. 2015-10-27
Journal Articles
- Case Report Long-Term Survival Following Transformation of an Adrenocorticotropic Hormone Secreting Pituitary Macroadenoma to a Silent Corticotroph Pituitary Carcinoma...James R Hackney, Kristen O Riley, Lauren E Rotman, T Brooks Vaughan, ScienceDirect
External Links
- UAB Pituitary/Thyroid Conference 2018http://uab.edu/medicine/endocrinology/news-events
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
